Mireille Yimtchui Towa , Achille Nouga Bissoue , Klev Gaïtan Sikam , Gervais Happi Mouthé , Moses K. Langat , Eduard Mas-Claret , Jean Duplex Wansi
{"title":"Three new cycloartane and friedelane triterpenoids from the leaves of Caloncoba flagelliflora","authors":"Mireille Yimtchui Towa , Achille Nouga Bissoue , Klev Gaïtan Sikam , Gervais Happi Mouthé , Moses K. Langat , Eduard Mas-Claret , Jean Duplex Wansi","doi":"10.1016/j.phytol.2025.02.007","DOIUrl":null,"url":null,"abstract":"<div><div>Three previously undescribed triterpenoids, caloncobic acid D (<strong>1</strong>), caloncobalactone D (<strong>2</strong>), and trichadenic acid C (<strong>3</strong>) were isolated from the leaves of <em>Caloncoba flagelliflora</em> (Mildbr.) Gilg ex Pellegr. Additionally, seven known compounds, trichadonic acid (<strong>4</strong>), glaucalactone C (<strong>5</strong>), glaucanoic acid (<strong>6</strong>), friedelin (<strong>7</strong>), sitosterol (<strong>8</strong>), and stigmasterol (<strong>9</strong>), along with stigmasterol 3-O-<em>β</em>-D-glucopyranoside (<strong>10</strong>), were identified. The structures of these compounds were elucidated using spectroscopic methods, including extensive 1D and 2D NMR techniques, chemical evidence, and comparison with literature data. Subsequently, compounds <strong>5–6</strong> and <strong>9–10</strong> were evaluated for antiplasmodial activity against two strains of <em>Plasmodium falciparum</em>: <em>Pf</em>Dd2 and <em>Pf</em>3D7. Compound <strong>6</strong> exhibited moderate activity, with IC<sub>50</sub> values of (7.5 ± 0.1 μM) and (10.0 ± 0.7 μM) against PfDd2 and Pf3D7, respectively. Compound <strong>10</strong> also moderately inhibited Pf3D7, with an IC<sub>50</sub> value of (7.5 ± 0.1 μM). These findings highlight C. <em>flagelliflora</em> as a valuable source of triterpenes and suggest their potential as candidates for new antiplasmodial drug development.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"66 ","pages":"Pages 105-110"},"PeriodicalIF":1.3000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390025010225","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Three previously undescribed triterpenoids, caloncobic acid D (1), caloncobalactone D (2), and trichadenic acid C (3) were isolated from the leaves of Caloncoba flagelliflora (Mildbr.) Gilg ex Pellegr. Additionally, seven known compounds, trichadonic acid (4), glaucalactone C (5), glaucanoic acid (6), friedelin (7), sitosterol (8), and stigmasterol (9), along with stigmasterol 3-O-β-D-glucopyranoside (10), were identified. The structures of these compounds were elucidated using spectroscopic methods, including extensive 1D and 2D NMR techniques, chemical evidence, and comparison with literature data. Subsequently, compounds 5–6 and 9–10 were evaluated for antiplasmodial activity against two strains of Plasmodium falciparum: PfDd2 and Pf3D7. Compound 6 exhibited moderate activity, with IC50 values of (7.5 ± 0.1 μM) and (10.0 ± 0.7 μM) against PfDd2 and Pf3D7, respectively. Compound 10 also moderately inhibited Pf3D7, with an IC50 value of (7.5 ± 0.1 μM). These findings highlight C. flagelliflora as a valuable source of triterpenes and suggest their potential as candidates for new antiplasmodial drug development.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.